MedTrace Logo

Hyperbaric Oxygen Post Established Stroke

NCT02582502 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2020-03-27

No results posted yet for this study

Summary

The purpose of this study is to examine the role of Hyperbaric Oxygen Therapy (HBOT) in improving neurological function in patients who are 6 to 36 months post ischemic stroke.

Conditions

Interventions

OTHER

Hyperbaric Oxygen

The only intervention given will be 100% oxygen under hyperbaric pressure.

Sponsors & Collaborators

  • University of British Columbia

    lead OTHER

Principal Investigators

  • David W Harrison, MD,CCFP(EM),FRCPC · Vancouver General Hospital and University of British Columbia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
19 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2020-01-31
Completion
2020-07-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02582502 on ClinicalTrials.gov